Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track SEPSF with free AI briefings, catalyst countdowns, and dilution alerts.

SEPSF · ASEP Medical Holdings Inc.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$215,226 Cash on Hand
2.1mo Cash Runway
Follow SEPSF by email Get an email when SEPSF reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about SEPSF, unsubscribe in one click. Privacy

💰 Cash Runway & Dilution Risk

SEPSF holds $215,226 in cash and short-term investments and burns about $308,298/quarter from operations, an estimated runway of 2.1 months at that rate (BioRadar estimate, not company guidance).

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when SEPSF files for a raise →

Get the full SEPSF picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for SEPSF and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.